Saltoro Capital, LP Acorda Therapeutics Inc Call Options Transaction History

Saltoro Capital, LP

0 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form

No transaction found.

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Saltoro Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Saltoro Capital, LP with notifications on news.